| Basics |
Insulet Corporation
Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
|
| IPO Date: |
May 15, 2007 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$21.42B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.75 | 1.89%
|
| Avg Daily Range (30 D): |
$5.76 | 1.76%
|
| Avg Daily Range (90 D): |
$4.69 | 1.45%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.46M |
| Avg Daily Volume (30 D): |
.58M |
| Avg Daily Volume (90 D): |
.52M |
| Trade Size |
| Avg Trade Size (Sh.): |
67 |
| Avg Trade Size (Sh.) (30 D): |
24 |
| Avg Trade Size (Sh.) (90 D): |
27 |
| Institutional Trades |
| Total Inst.Trades: |
9,884 |
| Avg Inst. Trade: |
$5.97M |
| Avg Inst. Trade (30 D): |
$20.48M |
| Avg Inst. Trade (90 D): |
$20.16M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$10.57M |
| Avg Closing Trade (30 D): |
$31.95M |
| Avg Closing Trade (90 D): |
$31.35M |
| Avg Closing Volume: |
56.78K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$1.24
|
$.32
|
|
Diluted EPS
|
|
$1.24
|
$.32
|
|
Revenue
|
$
|
$ 706.3M
|
$ 649.1M
|
|
Gross Profit
|
$
|
$ 510.1M
|
$ 452.2M
|
|
Net Income / Loss
|
$
|
$ 87.6M
|
$ 22.5M
|
|
Operating Income / Loss
|
$
|
$ 117.7M
|
$ 121.1M
|
|
Cost of Revenue
|
$
|
$ 196.2M
|
$ 196.9M
|
|
Net Cash Flow
|
$
|
$ -364.2M
|
$ -161.4M
|
|
PE Ratio
|
|
|
|
|
|
|
